SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008573
Filing Date
2022-05-09
Accepted
2022-05-09 17:13:52
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20220331.htm   iXBRL 10-Q 3366814
2 EX-10.1 fgen-ex10_1.htm EX-10.1 577446
3 EX-31.1 fgen-ex31_1.htm EX-31.1 11559
4 EX-31.2 fgen-ex31_2.htm EX-31.2 11536
5 EX-32.1 fgen-ex32_1.htm EX-32.1 11637
6 GRAPHIC img85605818_0.jpg GRAPHIC 2502
  Complete submission text file 0000950170-22-008573.txt   11887204

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fgen-20220331_def.xml EX-101.DEF 279945
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20220331_lab.xml EX-101.LAB 531800
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fgen-20220331_cal.xml EX-101.CAL 79416
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20220331_pre.xml EX-101.PRE 455367
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20220331.xsd EX-101.SCH 77665
64 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20220331_htm.xml XML 2168390
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 22906166
SIC: 2834 Pharmaceutical Preparations